ºÝºÝߣ

immunogenicity biologics cambridge healthtech institute structure-based drug design drug discovery drug delivery clinical diagnostics bioassays bioassay drug discovery technology immuno-oncology phenotypic screening clinical training pharma conference risk-based monitoring biotherapeutics tissue models immunogenicity course tissue engineering fda immunotherapy immunogenicity testing immunogenicity risk drug screening cancer immunotherapy course 3d models companion diagnostics diagnostics conference phenotypic drug discovery clinical trial conference clinical course clinical trial summit protein engineering drug design computational chemistry assays myeloma formulation point of care testing precision medicine gpcr immunogenicity assessment formulation strategies for biologics tumor models protein therapeutics antibody engineering liquid biopsy cancer immunotherapy 3d cell culture tumor biology antibody assays biomarkers immunogenicity conference bioinformatics epigenetic targets quality by design oncology computer-aided design pharmaceutical hematological cancers hematological malignancies cancer clinical auditing pk/pd point-of-care diagnostics patient recruitment adcs qbd tissue diagnostics bioassay conference assay drug organotypic models clinical vendors immune drug interference exosomes biological assay microvesicles biomarkers congress biochemistry clinical project management protein kinase in vitro cell models drug r&d drug safety kinase chemistry screening for drugs inhibitor drug development drug compounds gpcrs macrocyles sbdd nanomedicine nanotechnology sequencing chi genome insight pharma reports novel constructs immunogencity kevin davies cabd phenotype biotechnology and pharmaceuticals screening molecule structural biology epigenetics physicochemical properties toxicology cancer drug drug injections pulmonary nasal spray oral delivery technology medical device oral drug oral delivery drug delivery technology nasal delivery peptide therapeutics admet nmr rational drug design regulatory affairs pharma biologics delivery student fellowships assay development medicinal chemistry bioassays course pharmaceuticals melanoma upper gi ovarian cancer breast cancer colorectal cancer lung cancer tumors hematologic cancers john hopkins sidney kimmel comprehensive cancer ce yale cancer center leukemia pharma training hematologic malignancies solid tumors big data for clinical trials clinical summit big data ich e6 addendum clinical quality management rbm clinical trials genomics central lab sourcing biomarker trials lab and diagnostics services chi conferences next generation dx summit drug-diagnostic early cancer surveillance cancer diagnostics tumor microenvironment lymphoid tissues inflammatory diseases mscs stromal cells stroma cells molecular diagnostics machine learning health-it cloud computing biotechnology doe design of experiments dna forensics molecular diagnotics digital medicine clinical trial optimization artificial intelligence pharma outsourcing outsourcing for clinical trials clinical trial immuno-oncology course clinical operations i/o drug discovery 3d culture cancer target cell-based models hca hcs/a phenotypic cell-based drug discovery high content analysis organ on-a-chip drug screening conference 3d tissue models stem-cell derived models pharmacology conference toxicology conference pharmacy cell-free dna dx poc leukemias lymphomas pharma course healthcare course medical course hematology clinical investigation clinical investigative sites clinical research sample and biospecimen managmement pharmacokinetics antibodies biosimilars eczema inflammatory disease medical dermatology psoriasis acnea inflammatory skin diseases delivery technologies skin pharmacokinetics medical dermatology conference drug development in dermatology rosacea skin orphan skin disease skin cancer skin disease mechanisms dermatology antibody constructs bioassay course bioassay development drug lead optimization physiologically relevant assays 3d cell models immunotherapeutic approaches clinical monitoring